This segment is the core of Alfresa Holdings' operations, focusing on the wholesale and distribution of ethical pharmaceuticals, diagnostic reagents, and medical devices/equipment to hospitals, clinics, and dispensing pharmacies across Japan and internationally. The company leverages its extensive distribution network and logistics capabilities to ensure timely and efficient delivery of products. Research and development activities are primarily focused on improving supply chain efficiency, implementing digital solutions for order management, and enhancing cold chain logistics for temperature-sensitive products. The segment's market positioning is strong due to its established relationships with healthcare providers and its comprehensive product portfolio. Future opportunities include expanding into new markets, integrating advanced technologies for inventory management, and developing value-added services for customers. Regulatory compliance and adherence to stringent quality standards are critical aspects of this segment.

This segment focuses on the wholesale distribution of over-the-counter (OTC) drugs, health foods, supplements, and other self-medication products to drug stores and pharmacies. Alfresa Holdings utilizes its distribution network to provide a wide range of products to meet the diverse needs of consumers. Research and development activities are focused on market analysis, consumer behavior, and identifying emerging trends in the self-medication market. The company also focuses on optimizing its supply chain to ensure product availability and minimize costs. The segment's market positioning is driven by its extensive product portfolio, strong relationships with retail partners, and its ability to respond to changing consumer preferences. Future opportunities include expanding its product offerings, developing private-label brands, and leveraging digital platforms for online sales and marketing. Regulatory compliance with OTC drug regulations and ensuring product safety are critical aspects of this segment.

This segment encompasses the manufacturing and marketing of active pharmaceutical ingredients (APIs), pharmaceuticals, diagnostic reagents, and medical devices. It also includes contract manufacturing services for pharmaceutical companies. Research and development activities focus on the development of new pharmaceutical formulations, improving manufacturing processes, and exploring new technologies for medical devices. The company utilizes advanced manufacturing techniques and adheres to stringent quality control standards. The medical-related business includes dispensing pharmacies and other medical-related activities. The segment's market positioning is based on its manufacturing capabilities, product quality, and its ability to provide comprehensive healthcare solutions. Future opportunities include expanding its manufacturing capacity, developing new products, and entering into strategic partnerships. Regulatory compliance with pharmaceutical manufacturing standards and medical device regulations is a key focus.